Disease-modifying therapies for Parkinson disease: lessons from multiple sclerosis.
Kalia LV, Asis A, Arbour N, Bar-Or A, Bove R, Di Luca DG, Fon EA, Fox S, Gan-Or Z, Gommerman JL, Kang UJ, Klawiter EC, Koch M, Kolind S, Lang AE, Lee KK, Lincoln MR, MacDonald PA, McKeown MJ, Mestre TA, Miron VE, Ontaneda D, Rousseaux MWC, Schlossmacher MG, Schneider R, Stoessl AJ, Oh J.
Kalia LV, et al.
Nat Rev Neurol. 2024 Dec;20(12):724-737. doi: 10.1038/s41582-024-01023-0. Epub 2024 Oct 7.
Nat Rev Neurol. 2024.
PMID: 39375563
Review.